This study was aimed to collect baseline information pertaining to the immune status of HIV-TB co-infected patients and correlate the same with CD4+T cell counts and viral loads before the initiation of either anti-TB or anti-HIV treatments, assuming that the initial state of the immune environment may play a decisive role in the outcome of the drug therapies. Here, CD4 is linked to tuberculosis.